In order to elucidate the mechanisms of breast-feeding-induced resistance to respiratory syncytial virus (RSV) infection, groups of breast-fed and bottle-fed infants with this infection were tested at the onset of illness and then again 1 and 2 weeks later for the presence of interferon (IFN) as wel
Cellular immune response to infection with respiratory syncytial virus and influence of breast-feeding on the response
โ Scribed by Kazuaki Mito; Yasuo Chiba; Kazuhiro Suga; Tooru Nakao
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 534 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Little information about immunity to respiratory syncytial virus (RSV) and disease pathogenesis in elderly persons exists. Humoral immunity to RSV was assessed in 41 young, 56 healthy elderly, and 49 frail elderly adults by measuring baseline RSV specific IgG by enzyme immunoassay (EIA) and microneu
The immunological response of infants younger than six months to infection with respiratory syncytial virus (RSV) was studied in relation to clinical severity. IL-6 and IL-8 were found more frequently and at higher levels in the plasma samples of more severely ill patients and no significant differe
## Abstract The concept of heterologous Tโcell immunity postulates that nonspecific memory Tโcells recruited and reactivated in the context of an unrelated virus infection may contribute to protective antiviral immunity. Pulmonary infection with respiratory syncytial virus (RSV) of mice immune to l
The serum antibody responses of babies to the variable carboxy-terminal region of the attachment ( G ) protein of respiratory syncytial virus (RSV) have been analysed using paired acute and convalescent sera from infants experiencing their first RSV infection with viruses of known genotype. The vari
IFN-a and lamivudine, were treated with 16 weeks of 10 megaunits PBMC, peripheral blood mononuclear cell; SI, stimulation index; ALT, alanine transami-of recombinant IFN-a 2b (Intron-A; Schering-Plough, Welwyn Garnase. den City, England) subcutaneously three times a week and 100 mg From the Institu